Department of Oral and Maxillofacial Surgery, Zaozhuang Municipal Hospital, Zaozhuang, Shandong Province, China.
Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4495-4505. doi: 10.26355/eurrev_202004_21032.
Probiotics, nowadays are the effective in management of chronic periodontitis when used as an adjunct to non-surgical periodontal therapy. However, the beneficial effects of probiotics are varied with the nature of bacterial strain. Our meta-analysis aims at evaluating the magnitude of improvement in clinical and microbiological parameters, with administration of Lactobacillus reuteri alone in adjunct to scaling and root planning (SRP).
A digitalized database search was made in MEDLINE (PubMed), Scopus, CENTRAL (Cochrane Registry of Trials), Web of Science, and EMBASE, to identify eleven randomized clinical trials published within last decade (2009-2019), with double blind, placebo controlled study design. The data extraction was carried out and subject to both qualitative and quantitative synthesis. The primary outcomes assessed were gain in clinical attachment level (CAL), reduction in probing pocket depth (PPD), and reduction in microbial levels.
The meta-analysis plots were used to assess all the clinical outcomes. The mean difference of reduction in PPD at 21 days (MD-0.61) and 3 months (MD-0.40), and CAL gain at 3 month (MD-0.30) showed favourable response in the sites treated with probiotics containing Lactobacillus reuteri in addition to SRP. The meta-plots for major peridonto-pathogens constructed at 21 days follow-up, showed short-term effective reduction.
Within the limits of the study, Lactobacillus reuteri containing probiotics showed a significant clinical and microbiological benefit, however, the favourable effect was shown to be short-term.
当益生菌被用作非手术牙周治疗的辅助手段时,其在慢性牙周炎的治疗中具有显著效果。然而,益生菌的有益效果因细菌菌株的性质而异。我们的荟萃分析旨在评估单独使用罗伊氏乳杆菌(Lactobacillus reuteri)辅助牙周洁治和根面平整术(SRP)时,在临床和微生物参数方面的改善程度。
我们对 MEDLINE(PubMed)、Scopus、CENTRAL(Cochrane 临床试验注册中心)、Web of Science 和 EMBASE 中的数字化数据库进行了检索,以确定过去十年(2009-2019 年)发表的十一项采用双盲、安慰剂对照设计的随机临床试验。我们进行了数据提取,并对其进行了定性和定量综合分析。主要评估结果是临床附着水平(CAL)的增加、探诊袋深度(PPD)的减少和微生物水平的降低。
使用荟萃分析图来评估所有临床结果。在第 21 天(MD-0.61)和第 3 个月(MD-0.40)时 PPD 减少的平均值差异,以及第 3 个月时 CAL 增加的平均值差异(MD-0.30)显示,在接受含有罗伊氏乳杆菌的益生菌辅助 SRP 治疗的部位,具有良好的反应。在第 21 天随访时构建的主要牙周病原体的荟萃分析图显示出短期的有效减少。
在本研究的范围内,含有罗伊氏乳杆菌的益生菌显示出显著的临床和微生物效益,但这种有利影响是短期的。